Mirxes Faces Further Delay in FY2025 Results; US$14.80 Million Prepayment Review Triggers Independent Probe and Trading Suspension

Bulletin Express
04/02

Mirxes Holding Company Limited (Mirxes) announced an additional delay in releasing its FY2025 audited results after external auditor KPMG flagged issues involving 14 prepayment transactions totaling roughly US$14.80 million. Most of the transactions were executed in 2H 2025 for new projects that later stalled or failed to launch as planned.

Approximately US$9.50 million of the questioned prepayments has been returned by vendors, leaving about US$5.30 million still outstanding for completed or ongoing work. KPMG requires further independent review of these transactions before it can finalize the audit opinion.

To expedite resolution, the board unanimously established an Independent Investigation Committee (IIC) chaired by independent non-executive director Dr. Lam Sin Lai Judy and comprising Mr. Fang Xiao. The IIC has engaged Karas So LLP and Alvarez & Marsal Disputes and Investigations Limited to conduct a focused review of the 14 transactions, evaluate related internal-control compliance, and report findings directly to the board. The investigation is currently in progress.

Mirxes’ shares have been suspended from trading on the Hong Kong Stock Exchange since 9:00 a.m. on 1 April 2026 and will remain suspended until further notice. Shareholders and potential investors are advised to exercise caution when dealing in the company’s securities.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10